Market development prospects of peptide drugs

The peptide drug market shows huge development potential both globally and domestically. The following is a detailed analysis of its prospects:

Domestic market development prospects

From 2018 to 2022, the annual growth rate of the domestic peptide drug market is approximately 0.25%. Although the growth rate is relatively low, this is mainly due to the entry of centralized procurement for many products, which has led to price declines, especially insulin products. However, the demand for peptide drugs in diabetes, anti-tumor, anti-infection, neurological diseases and cardiovascular system diseases is still strong.

1、Main application areas:

• Diabetes: As the main application field, peptide drugs play an important role in the treatment of diabetes.
• Anti-tumor: The application of peptide drugs in the anti-tumor field is gradually increasing, especially in targeted therapy and immunotherapy.
• Anti-infection: In anti-infection treatment, peptide drugs show unique advantages.
• Nervous system diseases and cardiovascular system diseases: Peptide drugs in these fields are also gradually developing.

2、Growth rate analysis:

• Nutritional drugs, diagnostics and cardiovascular disease drugs: During 2018-2022, the compound annual growth rate of these fields exceeded 14%, showing strong growth momentum.
• Diabetes drugs, anti-tumor and anti-infective drugs: the annual compound growth rate has slowed down, but they are still important market components.

Global market development prospects

Globally, acetone drugs are mainly used to treat diabetes, heart disease and cancer. With the advancement of biotechnology, acetone drugs play a crucial role in disease treatment.

Treat diabetes:

• For example, global sales of semaglutide, a representative GLP-1 drug for the treatment of diabetes, surged from US$10 billion to US$21.1 billion in 2023 due to the expansion of therapeutic indications. The interest in the field of economic therapy demonstrates the huge potential of the economic therapy market.

Other application areas:

• Bone Disorders: Bone drugs have shown significant efficacy in the treatment of bone disorders.
• Cancer treatment: Acetone drugs continue to make progress in cancer treatment and immunotherapy.

Future outlook

Peptide drugs and diagnostic reagents are highly valued in China. In the next few years, a large number of peptide drugs and reagents will enter clinical trials, and some will be approved for production and sales. Currently, many peptide drug molecules that are marketed globally have not yet been launched in China. In particular, the use rate of the top ten peptide molecule products in global sales is still low in China.

• Clinical trials: As more peptide drugs and reagents enter clinical trials, more innovative products are expected to come to the market.
• Market potential: In fields such as tumors and diabetes, peptide drugs have broad development space in the domestic market and have huge potential.

In conclusion

The peptide drug market shows strong growth potential both globally and domestically. With the continuous advancement of biotechnology and the increase in market demand, peptide drugs will play an increasingly important role in disease treatment, especially in the fields of diabetes, obesity, tumors, anti-infection and cardiovascular diseases. In the domestic market, driven by policy support and technological progress, more peptide drugs and diagnostic reagents will enter clinical practice and the market in the future, promoting the rapid development of the entire peptide drug market.